Pyrrolidine derivatives as oxytocin antagonists

Details for Australian Patent Application No. 2004215661 (hide)

Owner Merck Serono SA

Inventors Valognes, Delphine; Schwarz, Matthias; Jorand-Lebrun, Catherine

Agent Griffith Hack

Pub. Number AU-B-2004215661

PCT Pub. Number WO2004/076407

Priority 03100477.3 27.02.03 EP

Filing date 16 February 2004

Wipo publication date 10 September 2004

Acceptance publication date 3 December 2009

International Classifications

C07D 207/22 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61P 15/06 (2006.01) Drugs for genital or sexual disorders

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/076407 Priority application(s): WO2004/076407

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

23 April 2009 Alteration of Name

  The name of the applicant has been altered to Merck Serono SA

3 December 2009 Application Accepted

  Published as AU-B-2004215661

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004215663-Process for the preparation of styrene

2004215658-Novel diazabicyclic aryl derivatives